Lichen International Limited (LICN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q4
the company's fundamental outlook is compromised by a 56.1% revenue decline and a persistent inability to achieve operational breakeven, as demonstrated by the -89.3% operating margin in 2025Q4.
Lichen International Limited (LICN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Key metrics vs top competitors for Lichen International Limited (LICN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.60 | $26.12M | -0.39 | -40.89% | -89.58% | -30.06% | — | |
| $9.82 | $2.22M | 0.49 | 1.34% | 0.32% | 0.16% | — | |
| $16.15 | $1.61M | -0.09 | 89.09% | -16.46% | — | — | |
| $1.76 | $638.43M | -14.23 | 34.99% | -5.26% | -20.84% | — | |
| $10.00 | $1.87B | 3.62 | 34.21% | 13.82% | 10.85% | — | |
| $47.81 | $7.64B | 20.79 | 13.6% | 7.37% | 9.09% | — |
Lichen International Limited (LICN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when LICN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Lichen International Limited (LICN) stock FAQ — growth, dividends, profitability & financials explained
Lichen International Limited (LICN) reported $66.0M in revenue for fiscal year 2025. This represents a 612% increase from $9.3M in 2014.
Lichen International Limited (LICN) saw revenue decline by 40.9% over the past year.
Lichen International Limited (LICN) reported a net loss of $28.1M for fiscal year 2025.
Lichen International Limited (LICN) has a return on equity (ROE) of -30.1%. Negative ROE indicates the company is unprofitable.
Lichen International Limited (LICN) had negative free cash flow of $23.5M in fiscal year 2025, likely due to heavy capital investments.